3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
3
Neoplasms
3
Breast Neoplasms
3
Pain
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Incontinence, Stress
1
Urinary Incontinence
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Urinary Retention (POUR)
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
PGS
1
Opioid-Induced Constipation
1
Neuropathy, Painful
1
Neuralgia
1
Multiple Endocrine Neoplasia Type 1
1
Low Anterior Resection Syndrome
1
Fatigue
1
Depression
1
Cancer Pain
1
Anxiety Disorders
1
Agnosia
1
Interventions
Yoga
1
Transcranial Magnetic Stimulation
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Radiofrequency Ablation
1
Lidocaine
1
Exercise Therapy
1
Electroacupuncture
1
Cryosurgery
1
Capsaicin
1
Amitriptyline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuralgia
×
Electroacupuncture
×
1 year
×
Clear all
NCT04917796
2026-01-30
ACT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
255 enrolled